<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>LA062789-0128</title>
	</head>
	<body>
		<main>
			<p><P> June 27, 1989, Tuesday, Orange County Edition  </P> <P> EARNINGS  </P> <P> SPI Pharmaceuticals Inc., which is owned primarily by ICN Pharmaceuticals Inc.,  posted record net income of $3.8 million for its second quarter ended May 31.  That represents a 27% increase from the $3 million reported for the same period  last year. Sales in the quarter rose 10% to $30.3 million from $27.5 million.  For the first half, net income totaled $6.4 million, 47% higher than the $4.4  million posted a year earlier. Sales increased 17% to $59.9 million from $51.1  million. The Costa Mesa-based pharmaceutical products manufacturer said sales  growth in its international operations, particularly in Mexico, contributed to  the second-quarter gains.  </P></p>
		</main>
</body></html>
            